All In Biotech

Drug Trial Radar · NCT07904728

Treating Contact Lens Discomfort With Cyclosporine 0.1% Ophthalmic Solution

A Clinical Evaluation of Treating Contact Lens Discomfort With Water-Free Cyclosporine 0.1% Ophthalmic Solution

Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Aug 25, 2026

Primary completion

Mar 15, 2027

Study completion Apr 15, 2027

Sponsor

Lead sponsor
Ocular Aesthetics, LLC dba Ocular Clinical TrialsAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Harrow Eye, LLC
First posted
Oct 29, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Of the 140 million contact lens (CL) wearers worldwide, most wear soft contact lenses. Despite major improvements in contact lens care, nearly 20% of wearers stop using lenses, with contact lens discomfort (CLD) being the main reason. This study aims to determine whether VEVYE, a water-free 0.1% cyclosporine ophthalmic solution indicated for the treatment of DED, can improve contact lens comfort in people with dry eye disease.

Conditions

  • Dry Eye Disease (DED)
  • Contact Lens Discomfort (CLD)

Interventions

  • Cyclosporine 0.1% Ophthalmic SolutionDrug

    Participants will be treated with VEVYE (water-free cyclosporine 0.1% ophthalmic solution) twice per day in each eye before and after contact lens use.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8)Time frame: Baseline compared to 12 weeks.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ocular Clinical Trials

    Houston, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.